NDC codes

FDA NDC Directory
Product NDC (as listed)70771-1833Labeler and product segments. Claims need a package NDC.
Product NDC at billing width70771-1833Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
70771-1833-17077118330170771183301100 TABLET in 1 BOTTLE (70771-1833-1)Marketed from May 20, 2023
70771-1833-3707711833037077118330330 TABLET in 1 BOTTLE (70771-1833-3)Marketed from May 20, 2023
70771-1833-57077118330570771183305500 TABLET in 1 BOTTLE (70771-1833-5)Marketed from May 20, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Sucralfate
Generic name (nonproprietary)
sucralfate
Active ingredients
Sucralfate — 1 g/1
Dosage form
Tablet
Route
Oral
Labeler
Zydus Lifesciences LimitedNDC labeler code 70771
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 215705
Marketing start
Listing expires
Other FDA classes
Organometallic Compounds (Chemical structure)
Identifiers
Product ID 70771-1833_3f731a84-c141-4e26-ade3-39a9e4ea30e3SPL ID 3f731a84-c141-4e26-ade3-39a9e4ea30e3SPL set ID 882b7596-f62c-4be2-8f67-e64310718baaRxCUI 314234UNII XX73205DH5
Pharmacologic class
Aluminum Complex

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771183301 followed by a unit qualifier and the quantity

Package 70771-1833-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Sucralfate tablets are indicated in: Short-term treatment (up to 8 weeks) of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70771-1833

What is NDC 70771-1833?
70771-1833 is the product NDC for Sucralfate, Sucralfate 1 g/1 tablet, listed with the FDA by Zydus Lifesciences Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Sucralfate.
What is the active ingredient?
Sucralfate.
Who is the labeler?
Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sucralfate?
65 other product NDCs are listed under this name. See all Sucralfate NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Sucralfate NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
SucralfateSucralfate 1 g/10mLSuspensionOralSafecor Health, LLC48433-22648433-0226-40
SucralfateSucralfate 1 g/1TabletOralCardinal Health 107, LLC55154-028155154-0281-00
SucralfateSucralfate 1 g/1TabletOralSafecor Health LLC48433-09148433-0091-20
SucralfateSucralfate 1 g/10mLSuspensionOralTorrent Pharmaceuticals Limited13668-75413668-0754-42
SucralfateSucralfate 1 g/10mLSuspensionOralChartwell RX, LLC62135-10662135-0106-44
SucralfateSucralfate 1 g/10mLSuspensionOralChartwell Governmental & Specialty RX, LLC68999-10668999-0106-24
SucralfateSucralfate 1 g/1TabletOralCoupler LLC67046-146967046-1469-03
Sucralfatesucralfate oralSucralfate 1 g/10mLSuspensionOralPrecision Dose, Inc.68094-04168094-0041-6168094-0041-62
SucralfateSucralfate 1 g/10mLSuspensionOralCosette Pharmaceuticals, Inc.0713-079100713-0791-75
SucralfateSucralfate 1 g/1TabletOralPreferred Pharmaceuticals Inc68788-877968788-8779-0368788-8779-09

All 66 Sucralfate NDCs

Other NDCs under ANDA 215705

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215705
ProductStrengthForm · routeLabelerProduct NDC
SucralfateSucralfate 1 g/1TabletOralNCS HealthCare of KY, LLC dba Vangard Labs0615-8653
SucralfateSucralfate 1 g/1TabletOralCoupler LLC67046-1469
SucralfateSucralfate 1 g/1TabletOralRedpharm Drug67296-2147
SucralfateSucralfate 1 g/1TabletOralNuCare Pharmaceuticals, Inc.68071-3812
SucralfateSucralfate 1 g/1TabletOralPreferred Pharmaceuticals Inc68788-8779
SucralfateSucralfate 1 g/1TabletOralBryant Ranch Prepack71335-2461
SucralfateSucralfate 1 g/1TabletOralViona Pharmaceuticals Inc72578-081

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in